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٠ේ⪺⺰ᢥ
1) Ma C., Winsor L., Daneshtalab M.: Quantification of spiroether isomers and herniarin of 
different parts of Matricaria matricarioides and flowers of Chamaemelum nobile. Phytochem. 
Anal., 18: 42-49, 2007. 
㩷 Abstract: A simple HPLC-PAD-MS method was established to quantitatively analyse two spiroether 
isomers (cis-en-yn-dicycloether and trans-en-yn-dicycloether) and the main coumarin, herniarin, in 
chamomile herbs, simultaneously. By using this method, the contents of these three compounds in the 
flowers of two chamomile species, Roman chamomile (Chamaemelum nobile) and pineapple weed 
(Matricaria matricarioides), as well as in different parts of pineapple weed, were investigated. It was 
found that the flowers of both herbs contained large amounts of cis-en-yn-dicycloether and 
trans-en-yn-dicycloether, with the trans-form being more abundant than the cis-form. The leaves of 
pineapple weed were found to have the highest concentration of cis-en-yn-dicycloether and herniarin than 
the other parts. HPLC-PAD-MS-guided isolation and identification of other constituents are also 
discussed.
㩷 㩷 㩷
㩷 2) Lee J., Ma C., Hattori M.: Quantification of ergosterol and ergosterol peroxide in several 
medicinal fungi by high performance liquid chromatography monitored with a diode array 
detection-atmospheric pressure chemical ionization-ion trap mass spectrometer. J. Trad. 
Med., 25: 18-23, 2008.㩷
㩷 Abstract: A high performance liquid chromatography-diode array detection-atmospheric pressure 
chemical ionization-ion trap mass spectrometry (HPLC-DAD-APCI-MS/MS) was applied to determine 
the contents of ergosterol and ergosterol peroxide (EPO) in seventeen fruiting bodies and five mycelia of 
medicinal fungi, which are used as important traditional or folk medicines for prevention and treatment of 
cancer. A comprehensive validation of the method, including sensitivity, lineartity, reproducibility and 
recovery was conducted using the optimized chromatographic conditions; an HPLC-DAD method was 
used for determination of ergosterol and an HPLC-APCI-Ion Trap MS method was adopted for 
determination of EPO. The calibration lines of ergosterol and EPO were obtained with R
2
>0.999 (both 
standard compounds), and the limits of detection (S/N=3) were estimated to be 16.4 and 1.8 ng, 
respectively. The relative standard deviations of the respective methods were less than 4.81 and 6.30% 
(n=5) for intraday and interday assays, and the recoveries were 94.6-98.4% and 93.0-99.6% for ergosterol 
and EPO, respectively. Of the medicinal fungi examined, the content of ergosterol was found to be the 
highest in the fruiting body of Grifola frondosa (0.283%, w/w), while that of EPO was the highest in the 
fruiting body of Ganoderma colossum (0.053%, w/w). The described analytical methods are rapid, 
accurate and applicable to the quantitative determination of ergosterol and EPO in other fungi and their 
commercial products. 
㩷 㩷 㩷
3) Wang Z., Ma C., Tang S., Xiao H., Kakiuchi N., Kida H., and Hattori M.: Qualitative and 
quantitative analysis of Swertia herbs by high performance liquid chromatography-diode 
array detector-mass spectrometry (HPLC-DAD-MS). Chem. Pharm. Bull., 56: 485-490, 
2008. 
㩷 Abstract: We evaluated the composition of Swertia herbs using high performance liquid 
chromatography-diode array detector-mass spectrometry (HPLC-DAD-MS). Eleven peaks of 6 species 
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were unequivocally identified by comparing their retention times, UV spectra, on-line electrospray 
ionization mass (ESI-MS) spectra, and collision-induced dissociation mass spectrometry/mass 
spectromety (CID-MS/MS) data with those of authentic compounds. We adopted wavelengths of 254nm, 
340 nm and 230 nm to simultaneously determine these 11 compounds. By comparing the overall DAD and 
total ion current (TIC) profiles of various samples, the 6 species were differentiated in terms of the 
occurrence and/or relative concentrations of the eleven compounds. Our novel validated HPLC-DAD-MS 
method not only facilitates quality control and identification of Swertia herbs, but is also applicable to 
systematic investigations of the distribution of secoiridoids, flavonoids, and xanthones in the genus 
Swertia.
4) Lee J., Ma C., Park D., Yoshimi Y., Hatanaka M., and Hattori M.: Transformation of 
ergosterol peroxide to cytotoxic substances by rat intestinal bacteria. Biol. Pharm. Bull., 31: 
949-954, 2008. 
㩷 Abstract: Ergosterol peroxide (EPO, 1) is a major antitumor sterol produced by edible or medicinal 
mushrooms. Following oral administration of 1 to rats or anaerobic in vitro incubation of 1 with rat fecal 
bacteria, three metabolites were detected and their structures were identified to be 5Į,6Į-epoxy- 
ergosta-8(14), 22-diene-3E, 7Į-diol (M1, 2), 5Į,6Į-epoxyergosta-8,22-diene-3E,7Į-diol (M2, 3), and 
5Į,6Į-epoxy-3E-hydroxyergosta-22-ene-7-one (M3, 4) by spectroscopic analysis. Of these, M2 and M3 
showed more potent inhibitory activity than the original compound 1 against proliferation of CACO-2, 
WiDr, DLD-1 and Colo320 human colorectal adenocarcinoma cells. These findings suggest that bacterial 
metabolites of EPO play a significant role in its cytotoxic activity against human colorectal cancer cells. 
㩷 㩷 㩷
㩷 5) El Dine R. S., El Halawany A. M., Nakamura N., Ma C., and Hattori M.: New lanostane 
triterpene lactones from the Vietnamese mushroom Ganoderma colossum (FR.) C. F. 
BAKER. Chem. Pharm. Bull., 56: 642-646, 2008. 
㩷 Abstract: Four new lanostane triterpene lactones (colossolactone I, colossolactone II, colossolactone III 
and colossolactone IV) were isolated from the Vietnamese mushroom Ganoderma colossum (FR.) C. F. 
BAKER along with five known compounds. The structures of the new compounds were determined on the 
basis of MS, NMR and circular dichroism. 
㩷
㩷 6) Chung M. H., Suzuki S., Nishihara T., and Hattori M.: Estrogenic effects of a Kampo 
formula, Tokishakuyakusan, in parous ovariectomized rats. Biol. Pharm. Bull., 31: 1145-1149, 
2008 
㩷 Abstract: Female hormone-dependent cancers and other diseases pose a serious health threat for women, 
and low-risk medicines against such cancers hve not yet been discovered. The present study examines the 
effects of the traditional Chinese herbal mixture, Tokishakuyakusan (TS) and 17E-estradiol on the uterus 
of parous ovariectomized rats. Uterine atrophy that causes a reduction in uterine tissue and the uterine 
cavity area, was induced by ovariectomy, and slightly recovered by the daily oral administration of TS for 
two weeks (1000 mg/kg body weight). TS restored the decreased plasma estradiol concentration due to 
ovariectomy. However the yeast two-hybrid assay showed that TS did not bind estrogen receptors Dand
Eand immunohistochemnical staining revealed that 17E-estradiol stimulated the protein expression of 
estrogen receptor D, progesterone receptor, c-fos and c-jun in the uterus, whereas TS did not. These results 
suggest that TS might be useful for treating menopausal syndromes among women, as well as for patients 
when hormone replacement therapy (HRT) with estrogen is contraindicated.
㩷
㩷 7) Wang Z., Tang S., Ma C. Toyooka N., Kida H., Kawasaki M. and Hattori M.: Determination 
of novel nitrogen-containing metabolites after oral administration of swertiamarin to rats. J. 
Trad. Med., 25: 29-34, 2008. 
㩷 Abstract: We investigated the metabolic fate of swertiamarin (1) in Wister rats. Swertiamarin (1) is a 
principal component of Swertia herbs used traditional medicine. Liquid chromatography/ion trap mass 
spectrometry detected new metabolites (R)-gentianol (4a) and (S)-gentianol (4b) in rat plasma, together 
with the known metabolite gentianine (2), all of which contained nitrogen. The structures of the 
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metabolites were identified by comparing the retention times, as well as MS and MS/MS spectra with 
those of authentic compounds, which were synthesized from swertiamarin (1). We prepared (S)-gentianol 
(4b) by stereoselective reduction from gentianone (3) which is a new oxidation product of gentianine (2),
and the absolute configuration was unequivocally determined using an improved Mosher’s method.
㩷
㩷 8) Wei Y., Ma C., Chen D., Hattori M.: Anti-HIV-1 protease triterpenoids from Stauntonia 
obovatifoliola Hayata subsp. intermedia. Phytochemistry, 69: 1875-1879, 2008. 
㩷 Abstract: Three triterpenoids, 16E-hydroxy-2,3-seco-lup-20(29)-ene-2,3-dioic acid (1), 3E,21E,24- 
trihydroxy-30-noroleana-12,20(29)-dien-28-oic acid (2) and 16E-hydroxylupa-1,20(29)-dien-3-one (3),
along with eleven known triterpenes were isolated from stems of Stauntonia obovatifoliola Hayata subsp. 
intermedia (Y.C. Wu) T. Chen. Their structures were determined by analysis of HR-EI/FAB-MS and 1D 
and 2D NMR spectroscopic data and comparison with those in the literature. Ten of the compounds 
showed inhibitory activity against HIV-1 protease.
㩷 㩷 㩷
㩷 9) Lee J., Miyashiro H., Nakamura N., and Hattori M.: Two new triterpenes from the rhizome 
of Dryopteris crassirhizoma, and inhibitory activities of its constituents on human 
immunodeficiency virus-1 protease. Chem. Pharm. Bull., 56: 711-714, 2008.㩷
㩷 Abstract: Two new hopane type triterpenes, named dryopteric acids A (1) and B (2), were isolated from 
the rhizome of Dryopteris crassirhizoma (Aspiadaceae) together with sixteen known compounds (3-18).
Of isolated compounds, ursolic acid (15), and dryopteric acid A (1) and B (2) showed potent inhibitory 
activities against HIV-1 protease with IC50 values of 8.9-44.5 PM. In addition, acetylated compounds 1
and 2 appreciably increased inhibitory activities with their IC50 values of 1.7 and 10.8 PM, respectively.㩷
㩷 㩷 㩷
㩷 10) Jin J., Nishihata T., Kakiuchi N., and Hattori M.: Biotransformation of C-glucosylisoflavone 
puerarin to estrogenic (3S)-equol in co-culture of two human intestinal bacteria. Biol. 
Pharm. Bull., 31: 1621-1625, 2008.㩷
㩷 Abstract: Puerarin and daidzein are the major naturally occurring isoflavones in leguminous plants. 
These two compounds are metabolized to equol by human intestinal flora. Here we isolated two intestinal 
bacteria capable of metabolizing puerarin and daidzein, respectively, from human feces. One of them, 
strain PUE, converted puerarin to daidzein by cleaving a C-glucosyl bond, whereas the other, strain DZE, 
converted daidzein to equol by reducing a double bond in ring C followed by elimination of  an oxo group. 
Based on the 16S ribosomal RNA gene sequence, strain DZE showed 85% similarity with Eggerthella 
lenta. Equol produced by strain DZE was identified as (3S)-equol through several analytical methods. 
Moreover, we obtained (3S)-equal from puerarin by coincubation with strain PUE and DZE. In addition, 
5-hydroxyequol was obtained from genistein by incubation with strain DZE.㩷
㩷
㩷 11) El Dine R. S., El Halawany A., Ma C., and Hattori M.: Anti-HIV-1 protease activity of 
lanostane triterpenes from the Vietnamese mushroom Ganoderma colossum. J. Nat. Prod.,
71: 1022-1026, 2008. 
㩷 Abstract: Four new lanostane triterpenes, colossolactone V (1), colossolactone VI (2), colossolactone VII 
(3), and colossolactone VIII (4), were isolated from the fruiting bodies of the Vietnamese mushroom 
Ganoderma colossum, together with the known compound colossolactone E (5). The structures of 1-4
were assigned on the basis of spectroscopic evidence, and their absolute configurations were determined 
by CD spectroscopy and the Mosher ester method. Compounds 1-5, as well as two previously isolated 
compounds [schisanlactone A (6) and colossolactone G (7)] from the same mushroom, were evaluated for 
inhibition of HIV-1 protease, with IC50 values for the most potent compounds ranging from 5 to 13Pg/mL.
㩷
㩷 12)㩷 Xu Q., Ma C., Wang W., Fu X., Tang C., and Hattori M.: Study on the nitric oxide generating 
effects from aristolochic acid in vitro. Eur. J. Mass Spectrom., 14: 231-237, 2008.㩷
㩷 Abstract: In this study, an in vitro nitric oxide [NO]-assay system based on the Griess reaction was used 
to investigate the [NO]-generating effects of aristolochic acid [AA] for the first time. AA was separated 
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into its different components, aristolochic acid I [AAI] and aristolochic acid II [AAII], by preparative 
HPLC. AAI and AAII were incubated with human intestine bacteria [HIB] or rat intestine bacteria [RIB]. 
A NO mixture generated from AAI and AAII by intestinal bacteria was observed and denitroso 
metabolites of AAI or AAII were detected in vitro by liquid chromatography/tandem mass spectrometry. 
Therefore, NO generation might be closely related to the metabolic process of AA in vitro. It suggested 
that one possible mechanism for the toxicity of AA may be due to the generation of NO from these 
compounds by intestinal bacteria.
㩷
13)
㩷
Ismail S. M. N., El Dine S. R., Hattori M., Takahashi K. and Ihara M.: Computer based 
design, synthesis and biological evaluation of novel indole derivatives as HCV NS3-4A 
serine protease inhibitors. Bioorg. Med. Chem., 16: 7877-7887, 2008. 
Abstract: A series of novel indoles were designed and their molecular modeling simulation study 
including fitting to a 3D pharmacophore model using CATALYST program and their docking into the NS3 
active site was examined as HCV NS3 protease inhibitor. Several compounds showed significant high 
simulation docking score and fit values. The designed compounds were synthesized and biologically 
evaluated in vitro using an NS3 protease binding assay, where compounds 10a-k showed significant 
inhibitory activity (҈67%inhibition at 100 Pg/mL). Of these, compounds 10c and 10f demonstrated 
potent HCV NS3 protease inhibitors with IC50 values of 15 and 13PM, respectively. Enantio-selective 
Michael addition of an indole derivative in the presence of catalytic amount of AlCl3 and quinine at room 
temperature afforded the adduct 7e in excellent yield with 73% ee. The product was converted into 10l,
which showed lower activity than the mixture of the corresponding diastereoisomers.㩷
㩷 㩷 㩷
㩷
14)
㩷
Tang S., Wang Z., Ma C., and Hattori M.: Simultaneous determination of ten bioactive 
constituents in Eucommia ulmoides leaves and Tochu tea products by high-performance 
liquid chromatography-diode array detector-mass spectrometry (HPLC-DAD-MS). J. 
Trad. Med., 25: 112-118, 2008. 
Abstract: Tochu tea products generated from the leaves of Eucommia ulmoides OLIVER are habitually 
consumed as a health beverage in Japan, China and Korea. Therefore, quality control of these products is 
important for safety and validity evaluation. A method using high-performance liquid chromatography- 
diode array detector/electrospray ionization mass spectrometry (HPLC-DAD-/ESI-MS) was established 
to simultaneously determine ten bioactive constituents including 2 iridoids, 2 phenolic acids and 6 
flavonoids in E. ulmoides leaves and Tochu tea products. Peaks were unequivocally identified by 
comparing retention times, on-line electrospray ionization mass (ESI-MS) spectra and UV data with those 
of reference compounds isolated from E. ulmoides leaves and Tochu tea products. All calibration curves of 
the ten compounds showed good linear regression (R > 0.9994) within test ranges. The new method 
provided satisfactory presicision and accuracy with overall intra-day and inter-day variations of 1.8 - 3.0% 
and 3.5-5.9%, respectively, and overall recovery ranging from 95.4 - 106.1% with relative standard 
deviations (RSDs) within 3.6% (n = 3) for the ten compounds analyzed. The exclusive selecitivity and 
excellent sensitivity of HPLC-DAD/ESI-MS provided comprehensive chemical information about the 
constituents of Tochu tea products and E. ulmoides leaves.㩷
㩷
15)
㩷
Ma C., Hattori M., Daneshtalab M., and Wang L.: Chlorogenic acid derivatives with alkyl 
chains of different lengths and orientations: Potent ǩ-glucosidase inhibitors. J. Med. 
Chem., 51: 6188-6194, 2008. 
Abstract: Į-Glucosidases play important roles in the digestion of carbohydrates and biosynthesis of viral 
envelope glycoproteins. Inhibitors of Į-glucosidase are promising candidates for the development of 
antitype II diabetics and anti-AIDS drug. Here, we report the synthesis and Į-glucosidase inhibitory 
activity of mono- and diketal/acetal derivatives of chlorogenic acid. The diketal drivatives showed more 
potent inhibitory activity than the monoketals. The 1,7-(5-nonanone) 3,4-(5-nonanone)-chlorogenic acid 
diketal showed remarkable inhibitory activity against Į-glucosidases with potency better than that of 
1-deoxynojirimycin hydrochloride. Four diastereomers of pelargonaldehyde diacetal and two of 
monoacetal derivatives of chlorogenic acid were synthesized in this study. They showed significant potent 
inhibition similar to or more potent than the ketal counterparts. Acetals with the alkyl chain oriented 
toward position 2 of chlorogenic acid showed more potent activity than those oriented toward position 6.
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㩷16)㩷 Lee J., Hattori M., Kim J.: Inhibition of HIV-1 protease and RNase H of HIV-1 reverse 
transcriptase activities by long chain phenols from the sarcotestas of Ginkgo biloba. Planta 
Med., 74: 532-534, 2008. 
Abstract: Nine long-chain phenols: four cardanols (1-4), two bilobols (5, 6) and three alkylsalicylic acids 
(7-9) were isolated from the CH2Cl2 extracts of the sarcotestas of Ginkgo biloba as HIV-1 protease (PR) 
inhibitors. From these phenols, the bilobols (IC50, 2.6-5.8 PM) and alkylsalicylic acids (IC50, 10.2-24.9 
PM) exhibited dose-dependent potent inhibitory activities on HIV-1 PR, while the cardanols did not. On 
the other hand, only the alkylsalicylic acids (IC50, 33.7-170.3 PM) inhibited the activities of RNase H of 
HIV-1 reverse transcriptase (RT), while all of the compounds failed to affect the RNA dependent DNA 
polymerase (RDDP) of HIV-1 RT. Therefore, we regard bilobols as a new class and selective inhibitors of 
HIV-1 PR; in addition, alkylsalicylic acids are elucidated as a new class of inhibitors against HIV-1 PR 
and RNase H of HIV-1 RT.
㩷
17)
㩷
Chuanasa T., Phromjai J., Lipipun V., Suzuki M., Pramyothin P., Hattori M., and Shiraki 
K.: Anti-herpes simplex virus (HSV-1) activity of oxyresveratrol derived from Thai 
medicinal plant: Mechanism of action and therapeutic efficacy on cutaneous HSV-1 
infection in mice. Antiviral Res., 80: 62-70, 2008. 
Abstract: Oxyresveratrol, a major compound purified from Artocarpus lakoocha, a Thai traditional 
medicinal plant, was evaluated for its mechanism of action and therapeutic efficacy on cutaneous herpes 
simplex virus (HSV) infection in mice. The inhibitory concentrations for 50% HSV-1 plaque formation of 
oxyresveratrol, three clinical isolates, thymidine kinase (TK)–deficient and phosphonoacetic acid 
(PAA)-resistant HSV-1 were 19.8, 23.3, 23.5, 24.8, 25.5 and 21.7 Pg/ml, respectively. Oxyresveratrol 
exhibited the inhibitory activity at the early and late phase of viral replication and inhibited the viral 
replication with pretreatment in one-step growth assay of HSV-1 and HSV-2. Oxyresveratrol inhibited late 
protein synthesis at 30 Pg/ml. The combination of oxyresveratrol and acyclovir (ACV) produced 
synergistic anti-HSV-1 effect, as characterized by the isobologram of plaque inhibition. Mice orally 
treated with oxyresveratrol (500 mg/kg/dose) dose at 8 h before and three times daily had significant delay 
in herpetic skin lesion development (P<0.05). Topical application of 30% oxyresveratrol ointment five 
times daily significantly delayed the development of skin lesions and protected mice from death 
(P<0.0001).
㩷
18)
㩷
Ngoc T., Hung T., Thuong P., Kim J., Choi J., Bae K., Hattori M., Choi C., Lee J., and Min 
B.: Antioxidative activities of galloyl glucopyranosides from the stem-bark of Juglans 
mandshurica. Biosci. Biotechnol. Biochem., 72: 2158-2163, 2008. 
Abstract: Two phenolics, 1,2,6-trigalloylglucose (1) and 1,2,3,6-tetragalloylglucose (2), isolated from the 
stem-bark of Juglans mandshurica were evaluated for their antioxidative activities. The results showed 
that compounds 1 and 2 exhibited strong scavenging activities against 1,1´-diphenyl-1-picrylhydrazyl 
(DPPH), 2,2´-azino-bis-(3-ethylbenzenthiazoline-6-sulphonic) acid, and superoxide radicals, and also had 
a significant inhibitory effect on lipid peroxidation and low-density lipoprotein (LDL) oxidation. The 
strong superoxide radical scavenging of 1 and 2 resulted from the potential competitive inhibition with 
xanthine at the active site of xanthine oxidase (OX). In addition, compounds 1 and 2 displayed significant 
lipoxygenase inhibitory activity, the mode of inhibition also being identified as competitive. In 
comparison, the antioxidative activities of compounds 1 and 2, together with gallic acid, indicated that the 
number of galloyl moieties could play an important role in the antioxidative activity.
㩷
19)
㩷
Ma C., Hattori M., Chen H., Cai S., and Daneshtalab M.: Profiling the phenolic compounds 
of Artemisia pectinata by HPLC-PAD-MSn. Phytochem. Anal., 19: 294-300, 2008. 
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Abstract: An HPLC-PADMS
n
 method was employed to profile the phenolic compounds of the aerial part 
of Artemisia pectinata (Neopallasia pectinata), a plant with no previous reports concerning its phenolic 
constituents. Three isomers of trans-caffeoylquinic acid accompanied by cis-5-caffeoylquinic acid, six 
isomers of trans-dicaffeoylquinic acid, two isomers of methyl trans-dicaffeoylquinate (including one new 
somer), a trans-caffeoylferuloylquinic acid and three flavanoids were identified unambiguously by 
analysis of their UV and MS
n
 spectra in comparison with standard compounds that were isolated from 
natural sources, or synthesised, or were surrogate standards (green coffee extract). Other compounds were 
identified by analysis or their UV and MS
n
 data in comparison with  those reported in the literature. MS
n
experiments also suggested the presence of groups of dicaffeoylquinic acid glycosides, caffeoylquinic 
acid diglycosides, caffeoylquinic acid glycosides and quinic acid diglycosides.
㩷
20)㩷 Yang X., Zhao J., Hattori M.: Three new triterpenoid saponins from the seeds of Aesculus
turbinata. J. Asian Nat. Prod. Res., 10: 259-265, 2008. 
Abstract: Three new triterpenoid saponins, named isoescins VIIa (1), VIa (2), and VIIIa (3), were isolated 
from the seeds of Aesculus turbinata and identified by spectroscopic analysis and chemical hydrolysis. 
Their structures were established as 21ȕ-O-tigloyl-28-O-acetylprotoaescigenin 3ȕ-O-[ȕ-D-
galactopyranosyl(1ψ2)][ȕ-D-glucopyranosyl(1ψ4)]-E-D-glucopyranosiduronic acid (Isoescin VIIa, 1),
21ȕ-O-(2-methylbutyryl)-28-O-acetylprotoaescigenin 3ȕ-O-[ȕ-D-glucopyranosyl(1 ψ 2)][ȕ-D-
glucopyranosyl(1 ψ 4)]-ȕ-D-glucopyranosiduronic acid (Isoescin VIa, 2), and 21ȕ-O-angeloyl- 
28-O-acetylbarringtogenol C 3ȕ-O-[ȕ-D-glucopyranosyl(1 ψ 2)][ȕ-D-glucopyranosyl(1 ψ 4)]-ȕ-D- 
glucopyranosiduronic acid (Isoescin VIIIa, 3).㩷
ቇળႎ๔ 㧔․೎⻠Ṷ㧘ࠪࡦࡐࠫ࠙ࡓ㧘ࡢ࡯࡚ࠢࠪ࠶ࡊ╬㧕
㩷 1) Jin J., Nishihata T., Kakiuchi N., Hattori M.: Biotransformation of C-glucosylisoflavone puerarin 
to estrogenic (3S)-equol in co-culture of two human intestinal bacteria. The 4th 
KSP-JSP-CCTCNM Joint Symposium on Pharmacognosy KOREA-JAPAN-CHINA Joint 
Symposium 2008, 2008, 6, 18-21, Gangneung, Korea. 
㩷 2) Chung M. H., Suzuki S., and Hattori M.: The mechanism differences between Tokishakuyakusan 
and 17beta-estradiol using parous ovariectomized rats. The 7
th
 International Symposium on 
Natural Medicine and Microflora, 2008, 8, 2-4, Toyama. 
3) El Halawany A. M., Chung M. H., Ma C., and Hattori M.: Estorogenic activity of hydroxyl- 
phenylalkanes and diarylheptanoids from Aframomum melegueta. The 7th International 
Symposium on Natural Medicine and Microflora, 2008, 8, 2-4, Toyama. 
4) Tobo T., Jin J., Chung M. H., Ma C., Hattori M.: Synthesis of enantiomeric enterolactone and 
enterodiol, and their estrogenic potency. The 7
th
 International Symposium on Natural Medicine and 
Microflora, 2008, 8, 2-4, Toyama. 
5) Furuhashi K., Chung M. H., Hattori M.: Effect of Tokishakuyakusan on ovary KiSS-1 mRNA 
expression in hypophysectomized (HPX) rats. The 7
th
 International Symposium on Natural 
Medicine and Microflora, 2008, 8, 2-4, Toyama. 
㩷 6) El Halawany A. M.: Estrogenic activity of some naturally occurring phenolics. The 7th
International Symposium on Natural Medicine and Microflora, 2008, 8, 2-4, Toyama. 
㩷 7) Ma C.: Chemistry and bioactivity of caffeoylquinic acid derivatives. The 7th International 
Symposium on Natural Medicine and Microflora, 2008, 8, 2-4, Toyama. 
㩷 8) Hattori M.: Two optical isomers of enterolignans produced by human intestinal bacteria. The 7th
International Symposium on Natural Medicine and Microflora, 2008, 8, 2-4, Toyama. 
㩷 9) ్ ᝰ㚍 ⿥⟤₺ ᅤፄ⬰ ዋ㕍᦯ㇱᓕ㓶㧦Aristorlochic acid෸߮㑐ㅪൻว‛
᳿ቯߩߚ߼ߩ LC/MSᴺߩ㐿⊒ᣣᧄ⮎ቇળ╙  ᐕળᮮᵿ
㩷 10) ๓ ୃ⚃㚍 ⿥⟤᦯ㇱᓕ㓶₺ ༑ァ₺ ⪛㣮㊁⟤ᒄ㧦% ဳ⢄Ἳ࠙ࠗ࡞ࠬࡊࡠ
࠹ࠕ࡯࠯ߦኻߔࠆᾢ⢙ߩᵴᕈߦߟ޿ߡᣣᧄ⮎ቇળ╙  ᐕળᮮᵿ
㩷 11) 㒸 ℓḗ᦯ㇱᓕ㓶㧦ᬀ‛࡝ࠣ࠽ࡦઍ⻢ߦ㑐ਈߔࠆ⣺ౝ⚦⩶ Ruminococcus sp. END-1ߩ
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ઍ⻢․ᕈߦߟ޿ߡᣣᧄ⮎ቇળ╙  ᐕળᮮᵿ
㩷 12) ૒⮮⋥ੱ㚍 ⿥⟤㒸 ᓼᇫ᦯ㇱᓕ㓶㧦⚡⦼ Ganoderma sinenseᚑಽߩ HIVࡊࡠ࠹
ࠕ࡯࠯㒖ኂᵴᕈᣣᧄ⮎ቇળ╙  ᐕળᮮᵿ
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1) Hattori M.: Searching for anti-HIV agents among traditional medicines. The 2nd Global Summit 
on HIV/AIDS, Traditional Medicine & Indigenous Knowledge, 2008, 3, 10-14, Acra, Ghana.  
2) Hattori M.: Metabolic process of lignans to phytoestrogens enterodiol and enterolactone by human 
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㩷
㩷
4) Hattori M.: Metabolic activation of foods and natural medicines by human intestinal bacteria. 2008 
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ቇౝ
ٻ 1)ٻ ⣺ౝህ᳇ᕈ⩶ߦࠃࠆ↢⮎ᚑಽߩઍ⻢  ንጊᄢቇ⮎ቇㇱ ⿒የశᤘ
2)
3)
᛫ HSV⮎ߩ㐿⊒⎇ⓥ  ንጊᄢቇකቇㇱ ⊕ᧁ౏ᐽ
૕ౝᅚᕈࡎ࡞ࡕࡦߦਈ߃ࠆ๺ṽ⮎ߩᓇ㗀ߦ㑐ߔࠆ⎇ⓥ  ንጊᄢቇ๺ṽක⮎ቇ✚ว⎇ⓥ
ᚲ ᧻ᧄᰵਃ
࿖ౝ
1) ᛫ HCV⮎ߩ㐿⊒⎇ⓥ  ᘮᔕᄢቇකቇㇱ ਅ㆙㊁㇌ᔘ
ᘮᔕᄢቇ⮎ቇㇱ ਅ㆙㊁ਭ⟤ሶ
㊄ᴛᄢቇ⥄ὼ⑼ቇ⎇ⓥ⑼ ၂ౝାሶ
ᶏᄖ
1) ᛫ HSV⮎㐿⊒⎇ⓥ  ࠴ࡘ࡜ࡠࡦࠦࡦᄢቇ Pornpen Pramyothin 
٠⎇ⓥ⾌ขᓧ⁁ᴫ 㩷
㩷 1) ޟ߶ߊࠅߊஜᐽഃㅧࠢ࡜ࠬ࠲࡯ޠ㧔⽷㧕ർ㒽↥ᬺᵴᕈൻ࠮ࡦ࠲࡯㧔᦯ㇱ ಽᜂ㧕100ਁ౞.
㩷 2) ޟࡅ࠻ᣧ⊒ᕈ⠧ൻ∝୥⟲ࡕ࠺࡞ࠍ↪޿ߚ๺ṽ⮎ߩ↢ᱺེ࡮ⴊ▤߳ਈ߃ࠆᓇ㗀ޠᐔᚑ 20ᐕ
ᐲቇ㐳ⵙ㊂⚻⾌㧔㈕ ઍ⴫㧕100ਁ౞.
㩷 3) ޟવ⛔⮎‛ߦࠃࠆ↢૕ᯏ⢻ߩ㕟ᣂ⊛⸃ᨆ߅ࠃ߮ഃ⮎ᚢ⇛ޠᐔᚑ 20ᐕᐲቇ㐳ⵙ㊂⚻⾌㧔㚍
ಽᜂ㧕㧔㈕ ಽᜂ㧕
㩷 4) ޟࡅ࠻⣺ౝ⚦⩶ߦࠃࠆ lipoaconitineઍ⻢ᯏ᭴ߩൻቇ⊛⸃᣿ޠᐔᚑ 20ᐕᐲ╣Ꮉ⑼ቇ⎇ⓥഥᚑ
㊄㧔₺உ㧕55ਁ౞.
㩷 5) ޟੱෳട᳓ಽ⸃↥‛࠻࡝࠹࡞ࡍࡦ⺃ዉ૕ߩ᛫ HIV protease߅ࠃ߮᛫ HCV protease૞↪ߦ
㑐ߔࠆ⎇ⓥޠ2008ᐕᐲᣣਛකቇදળ౒ห⎇ⓥ╬ഥᚑ㊄㧔ෂ⧷㧕60ਁ౞.
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Swertiamarinߩ࡜࠶࠻ߦ߅ߌࠆᣂⷙ฽⓸⚛ઍ⻢‛ߩหቯ㧔4᦬㧕
 㒸ℓḗ㧦ࡅ࠻⣺ౝ⚦⩶ߦࠃࠆᬀ‛࡝ࠣ࠽ࡦߩູ੃㘃࡝ࠣ࠽ࡦ߳ߩઍ⻢ㆊ⒟ߩ⸃᣿㧔9᦬㧕
Riham Salah El Din㧦ࡧࠚ࠻࠽ࡓ↥ࠠࡁࠦ Ganoderma colossum߆ࠄන㔌ߒߚ HIV-1ࡊࡠ࠹
ࠕ࡯࠯ߦኻߔࠆੑ㊂૕߅ࠃ߮ᵴᕈㇱ૏㒖ኂ‛⾰㧔9᦬㧕
㩷
㩷
㩷 㩷
㩷 㩷
㩷 㩷
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